Accordingly, in this study, we aimed to investigate the FABP4/FOXO1 pathway in a streptozotocin-induced DN model to elucidate the mechanisms of metformin by which it potentially delays or prevents early renal senescence. Here, FABP4 is linked to liver dysplastic nodule.